124 related articles for article (PubMed ID: 1345141)
1. Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment.
Dahlöf B; Stenkula S; Hansson L
Blood Press; 1992 May; 1(1):35-44. PubMed ID: 1345141
[TBL] [Abstract][Full Text] [Related]
2. Regression of left ventricular hypertrophy in previously untreated essential hypertension: different effects of enalapril and hydrochlorothiazide.
Dahlöf B; Hansson L
J Hypertens; 1992 Dec; 10(12):1513-24. PubMed ID: 1338083
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of retinal vascular changes in never-treated essential hypertensives: an inter- and intra-observer reproducibility study with non-mydriatic retinography.
Cuspidi C; Salerno M; Salerno DE; Meani S; Valerio C; Esposito A; Catini E; Magrini F; Zanchetti A
Blood Press; 2004; 13(1):25-30. PubMed ID: 15083637
[TBL] [Abstract][Full Text] [Related]
4. Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy.
Dahlöf B
Blood Press Suppl; 1992; 6():1-75. PubMed ID: 1345261
[TBL] [Abstract][Full Text] [Related]
5. The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide.
Dahlöf B; Hansson L
J Intern Med; 1993 Sep; 234(3):271-9. PubMed ID: 8354977
[TBL] [Abstract][Full Text] [Related]
6. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
Dahlöf B; Herlitz H; Aurell M; Hansson L
Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
[TBL] [Abstract][Full Text] [Related]
7. Retinal arteriolar narrowing and left ventricular hypertrophy in African Americans. the Atherosclerosis Risk in Communities (ARIC) study.
Tikellis G; Arnett DK; Skelton TN; Taylor HW; Klein R; Couper DJ; Richey Sharrett A; Yin Wong T
Am J Hypertens; 2008 Mar; 21(3):352-9. PubMed ID: 18246060
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
9. Effects of diltiazem, metoprolol, enalapril and hydrochlorothiazide on frequency of ventricular premature complexes.
Papademetriou V; Narayan P; Kokkinos P
Am J Cardiol; 1994 Feb; 73(4):242-6. PubMed ID: 7507638
[TBL] [Abstract][Full Text] [Related]
10. Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries.
Thürmann PA; Stephens N; Heagerty AM; Kenedi P; Weidinger G; Rietbrock N
Hypertension; 1996 Sep; 28(3):450-6. PubMed ID: 8794832
[TBL] [Abstract][Full Text] [Related]
11. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
[TBL] [Abstract][Full Text] [Related]
12. Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.
González-Juanatey JR; Reino AP; García-Acuña JM; Varela Román A; Calvo Gómez C; Cabezas-Cerrato J
Am J Cardiol; 1998 Jan; 81(1):87-90. PubMed ID: 9462614
[TBL] [Abstract][Full Text] [Related]
13. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).
Devereux RB; Dahlof B; Levy D; Pfeffer MA
Am J Cardiol; 1996 Jul; 78(1):61-5. PubMed ID: 8712120
[TBL] [Abstract][Full Text] [Related]
14. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
[TBL] [Abstract][Full Text] [Related]
15. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
Gosse P; Sheridan DJ; Zannad F; Dubourg O; Guéret P; Karpov Y; de Leeuw PW; Palma-Gamiz JL; Pessina A; Motz W; Degaute JP; Chastang C
J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435
[TBL] [Abstract][Full Text] [Related]
16. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group.
Papademetriou V; Gottdiener JS; Narayan P; Cushman WG; Zachariah PK; Gottdiener PS; Chase GA
J Am Coll Cardiol; 1997 Dec; 30(7):1802-8. PubMed ID: 9385910
[TBL] [Abstract][Full Text] [Related]
17. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril.
González-Juanatey JR; Pose Reino A; Román AV; García Acuña JM; Fernández López JA; Cerrato JC
Am J Cardiol; 1997 Feb; 79(3):373-6. PubMed ID: 9036764
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular changes after chronic therapy with enalapril maleate in moderate to severe hypertensive patients.
Fernandez PG; Kim BK; Snedden W; Nolan R; Ko P
Curr Med Res Opin; 1984; 9(3):170-83. PubMed ID: 6094104
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination?
Cuspidi C; Macca G; Salerno M; Michev L; Fusi V; Severgnini B; Corti C; Meani S; Magrini F; Zanchetti A
Ital Heart J; 2001 Sep; 2(9):702-6. PubMed ID: 11666100
[TBL] [Abstract][Full Text] [Related]
20. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
Schiffrin EL; Park JB; Pu Q
J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
